Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Abstrait

Appearances of Stigma and Discrimination among Immunocompromised Female Injecting Drug Users (Fidu) - A Study in Champai, Mizoram in India

Gautam Kr Ghosh, Vanlalhumi

In India the HIV positivity in among IDUs stands at a staggering 7.71. Injecting drug use among female appear to mirror patterns among males, but with greater adverse consequences. They are still a group of population that lacks visibility, and are subjected to multiple layers of stigma because they belong to socially deviant and disenfranchised groups with facing gender-specific inequality and exclusion. The study aimed at understanding the ways in which FIDUs Champai district of Mizoram indigenous minority community, experience stigma and discrimination and the impacts that stigma and discrimination may have on their abilities to access health services. The qualitative study also used content analysis and the health stigma and discrimination framework analysis. The study found several forms of stigma among female injecting drug user that deters their access and utilization of health services and suggested a range of specific gender-specific individual-, social-, and structural-level interventions.